Marker Therapeutics News

Marker Therapeutics | 8-K: Current report

Jun 12 16:08 ET

Marker Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Enterprise Associates 16, L.P.(12.0%),NEA Partners 16, L.P.(12.0%), etc.

May 17 18:28 ET

Marker Therapeutics | 8-K: Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 15 16:49 ET

Marker Therapeutics | 10-Q: Quarterly report

May 15 16:06 ET

Marker Therapeutics | ARS: Annual Report to Security Holders

Apr 26 16:34 ET

Marker Therapeutics | DEF 14A: Definitive information statements

Apr 26 16:11 ET

Marker Therapeutics | 8-K: Current report

Apr 8 07:12 ET

Marker Therapeutics | 10-K: Annual report

Mar 26 13:28 ET

Marker Therapeutics | 8-K: Current report

Mar 26 13:28 ET

Marker Therapeutics | 8-K: Current report

Mar 1 08:06 ET

Marker Therapeutics | 8-K: Current report

Feb 26 08:00 ET

Marker Therapeutics | 8-K: Current report

Jan 8 00:00 ET

Marker Therapeutics | 8-K: Current report

Dec 11, 2023 07:35 ET

Marker Therapeutics | 8-K: Current report

Nov 20, 2023 16:37 ET

Marker Therapeutics | 8-K: Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Nov 9, 2023 17:03 ET

Marker Therapeutics: Q3 2023 Earnings Report

Nov 9, 2023 16:31 ET

Marker Therapeutics | 8-K: Current report

Sep 11, 2023 07:10 ET

Marker Therapeutics | 8-K: Marker Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 14, 2023 16:37 ET

Marker Therapeutics | 10-Q: Q2 2023 Earnings Report

Aug 14, 2023 16:03 ET

Marker Therapeutics | 8-K: Current report

Aug 7, 2023 07:22 ET